[Federal Register Volume 68, Number 243 (Thursday, December 18, 2003)]
[Notices]
[Pages 70512-70513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-31157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee Information Hotline

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that we 
have revised the Advisory Committee Information Hotline (the hotline). 
The hotline provides the public with access to the most current 
information available on FDA advisory committee meetings. This notice 
supersedes all previously published announcements of FDA's Advisory 
Committee Information Hotline.

FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Committee Management 
Officer (HF-4), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-1220.

SUPPLEMENTARY INFORMATION: The Advisory Committee Information Hotline 
can be accessed by dialing 1-800-741-8138 or 301-443-0572. The advisory 
committee meeting information and information updates can also be 
accessed via FDA's Advisory Committee calendar at http://www.fda.gov/oc/advisory/accalendar/accalendar.html.
    Each advisory committee is assigned a 10-digit number. This 10-
digit number will appear in each individual notice of meeting. The 
public can obtain information about a particular advisory committee 
meeting by using the committee's 10-digit number. Information on the 
hotline is preliminary and may change before a meeting is actually 
held. The hotline will be updated when such changes are made. The 
following is a list of each advisory committee's 10-digit number to be 
used when accessing the hotline.

------------------------------------------------------------------------
              ADVISORY COMMITTEE                         NUMBER
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER..............................................
  Science Board to the FDA...................  3014512603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH............................
  Allergenic Products Advisory Committee.....  3014512388
  Biological Response Modifiers Advisory       3014512389
   Committee.
  Blood Products Advisory Committee..........  3014519516
  Transmissible Spongiform Encephalopathies    3014512392
   Advisory Committee.
  Vaccines and Related Biological Products     3014512391
   Advisory Committee.
CENTER FOR DRUG EVALUATION AND RESEARCH.................................
  Anesthetic and Life Support Drugs Advisory   3014512529
   Committee.
  Anti-Infective Drugs Advisory Committee      3014512530
   (Peds SubC).
  Antiviral Drugs Advisory Committee.........  3014512531
  Arthritis Advisory Committee...............  3014512532
  Cardiovascular and Renal Drugs Advisory      3014512533
   Committee.

[[Page 70513]]

 
  Dermatologic and Ophthalmic Drugs Advisory   3014512534
   Committee.
  Drug Safety and Risk Management Advisory     3014512535
   Committee (Drug Abuse Subcommittee).
  Endocrinologic and Metabolic Drugs Advisory  3014512536
   Committee.
  Gastrointestinal Drugs Advisory Committee..  3014512538
  Nonprescription Drugs Advisory Committee...  3014512541
  Oncologic Drugs Advisory Committee.........  3014512542
  Peripheral and Central Nervous System Drugs  3014512543
   Advisory Committee.
  Pharmaceutical Science, Advisory Committee   3014512539
   for.
  Psychopharmacologic Drugs Advisory           3014512544
   Committee.
  Pulmonary-Allergy Drugs Advisory Committee.  3014512545
  Reproductive Health Drugs, Advisory          3014512537
   Committee for.
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION............................
  Food Advisory Committee (full committee and  3014510564
   subcommittees).
    Additives and Ingredients Subcommittee     .........................
    Biotechnology Subcommittee...............
    Contaminants and Natural Toxicants
     Subcommittee.
    Dietary Supplements Subcommittee.........
    Infant Formula Subcommittee..............
    Nutrition Subcommittee...................
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH..............................
  Device Good Manufacturing Practice Advisory  3014512398
   Committee.
  Medical Devices Advisory Committee           N/A
   (comprised of 18 panels).
    Anesthesiology and Respiratory Therapy     3014512624
     Devices Panel.
    Circulatory System Devices Panel.........  3014512625
    Clinical Chemistry and Clinical            3014512514
     Toxicology Devices Panel.
    Dental Products Panel....................  3014512518
    Ear, Nose, and Throat Devices Panel......  3014512522
    Gastroenterology-Urology Devices Panel...  3014512523
    General and Plastic Surgery Devices Panel  3014512519
    General Hospital and Personal Use Devices  3014512520
     Panel.
    Hematology and Pathology Devices Panel...  3014512515
    Immunology Devices Panel.................  3014512516
    Medical Devices Dispute Resolution Panel.  3014510232
    Microbiology Devices Panel...............  3014512517
    Molecular and Clinical Genetics Panel....  3014510231
    Neurological Devices Panel...............  3014512513
    Obstetrics-Gynecology Devices............  3014512524
    Ophthalmic Devices Panel.................  3014512396
    Orthopaedic and Rehabilitation Devices     3014512521
     Panel.
    Radiological Devices Panel...............  3014512526
  National Mammography Quality Assurance       3014512397
   Advisory Committee.
  Technical Electronic Product Radiation       3014512399
   Safety Standards Committee.
CENTER FOR VETERINARY MEDICINE..........................................
  Veterinary Medicine Advisory Committee.....  3014512548
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH..............................
  Science Advisory Board to NCTR.............  3014512559
  Advisory Committee on Special Studies        3014512560
   Relating to the Possible Long-Term Health
   Effects of Phenoxy Herbicides and
   Contaminants.
------------------------------------------------------------------------

    The hotline will provide the most recent information available on 
upcoming advisory committee meetings, guidance for making an oral 
presentation during the open public hearing portion of a meeting, and 
procedures on obtaining copies of transcripts of advisory committee 
meetings. Because the hotline will communicate the most current 
information available about any particular advisory committee meeting, 
this system will provide interested parties with timely and equal 
access to such information. The hotline should also conserve agency 
resources by reducing the current volume of inquiries individual FDA 
offices and employees must handle concerning advisory committee 
schedules and procedures.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: December 10, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-31157 Filed 12-17-03; 8:45 am]
BILLING CODE 4160-01-S